Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39362249

Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2024 Oct
First author
Wolf J

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Oct;25(10):1249-1251. doi: 10.1016/S1470-2045(24)00492-3.
    note
    Source null
    related pmid
    39362243
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2024 Nov;25(11):e542. doi: 10.1016/S1470-2045(24)00560-6.
    note
    Source null
    related pmid
    39366396
    relationship
    Erratum in

Authors and identifiers

  1. name
    Wolf J
    type
    Author
  2. name
    Hochmair M
    type
    Author
  3. name
    Han JY
    type
    Author
  4. name
    Reguart N
    type
    Author
  5. name
    Souquet PJ
    type
    Author
  6. name
    Smit EF
    type
    Author
  7. name
    Orlov SV
    type
    Author
  8. name
    Vansteenkiste J
    type
    Author
  9. name
    Nishio M
    type
    Author
  10. name
    de Jonge M
    type
    Author
  11. name
    Akerley W
    type
    Author
  12. name
    Garon EB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wolf J
    type
    Author
  2. name
    Hochmair M
    type
    Author
  3. name
    Han JY
    type
    Author
  4. name
    Reguart N
    type
    Author
  5. name
    Souquet PJ
    type
    Author
  6. name
    Smit EF
    type
    Author
  7. name
    Orlov SV
    type
    Author
  8. name
    Vansteenkiste J
    type
    Author
  9. name
    Nishio M
    type
    Author
  10. name
    de Jonge M
    type
    Author
  11. name
    Akerley W
    type
    Author
  12. name
    Garon EB
    type
    Author
bibliography ids
  1. nci-bib-1df1e6aa6b375fff9c8badb9
book metadata
content sha256
b302aff3e75000dfed518bd30e66eb8e09ac94af089e26df4f886a9b91ea46f3
document type
citation
dois
  1. 10.1016/S1470-2045(24)00441-8
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:39362249
immutable id
pubmed:39362249@b302aff3e75000dfed518bd30e66eb8e09ac94af089e26df4f886a9b91ea46f3
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1357-1370
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Oct;25(10):1249-1251. doi: 10.1016/S1470-2045(24)00492-3.
    note
    Source null
    related pmid
    39362243
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2024 Nov;25(11):e542. doi: 10.1016/S1470-2045(24)00560-6.
    note
    Source null
    related pmid
    39366396
    relationship
    Erratum in
outcomes validated
false
pmid
39362249
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
fdb4dd9a9359b275a68f4063a8ad73dae1f31f5b73e3bcd7b5b682baae69b8c9
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2024 Oct
precision
month
year
2024
publication types
  1. Journal Article
  2. Clinical Trial, Phase II
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39362249/
title
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.

Preserved source evidence · Not medical advice